Shire's juggling act

By licensing balsalazide from Salix Pharmaceuticals Ltd., Shire Pharmaceuticals Group plc now has two products to treat ulcerative colitis. SHP already owns U.S. rights to Pentasa as

Read the full 277 word article

How to gain access

Continue reading with a
two-week free trial.